Evaluation of Efficacy of Gefarnate in Treatment of Chronic Atrophic Gastritis with Intestinal Metaplasia

作者
Lai Yue-xin
出处
期刊:Chinese Journal of Gastroenterology [Shanghai Institute of Digestive Diseases]
被引量:1
摘要

Chronic atrophic gastritis with intestinal metaplasia was considered as gastric precancerous lesions.Exploring effective drugs for its treatment is of great significance in reducing the morbidity and mortality of gastric cancer.Aims: To study the efficacy of gefarnate for the treatment of chronic atrophic gastritis with intestinal metaplasia.Methods: A total of 133 cases of chronic atrophic gastritis with intestinal metaplasia were enrolled and randomly assigned into gefarnate group and control group.Patients in gefarnate group were given gefarnate 100 mg tid for 3 months,and patients in control group were given Weifuchun 1400 mg tid for 3 months.Before and 3 months after treatment,subtyping of intestinal metaplasia was demonstrated by AB-PAS and HID-AB staining,and the inflammation degree of gastric mucosa was determined by HE staining.Results: The rate of chronic atrophic gastritis with intestinal metaplasia reversed to nonatrophic gastritis(reversal rate) in gefarnate group was significantly higher than that in control group(32.84% vs.15.15%,P = 0.017) 3 months after treatment.The reversal rate of incomplete-type small intestinal metaplasia in gefarnate group was significantly higher than that in control group(48.28% vs.16.67%,P = 0.016).The reversal rate of complete-type small intestinal metaplasia in gefarnate group was higher than that in control group but not reaching statistical significance(33.33% vs.16.67%,P = 0.375).The reversal rate of small intestinal metaplasia was significantly higher than the reversal rate of colon metaplasia in gefarnate group(44.74% vs.17.24%,P = 0.018).The inflammation degree of gastric mucosa in gefarnate group was significantly lower than that in control group(χ2= 11.061,P = 0.011).Conclusions: Gefarnate is effective for chronic atrophic gastritis,and it can reverse incomplete-type small intestinal metaplasia.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xiaohai1466完成签到 ,获得积分10
刚刚
时尚若雁完成签到,获得积分10
刚刚
安琪完成签到,获得积分10
刚刚
vdhuec完成签到,获得积分10
1秒前
紫炫完成签到 ,获得积分10
2秒前
leiyuekai完成签到 ,获得积分10
2秒前
慧子完成签到,获得积分10
3秒前
冷傲太英完成签到,获得积分10
3秒前
gaga完成签到,获得积分10
3秒前
九月初完成签到 ,获得积分10
4秒前
小白加油完成签到 ,获得积分10
4秒前
鲤鱼白枫完成签到,获得积分10
4秒前
2319374525完成签到,获得积分10
5秒前
抹茶麻薯完成签到 ,获得积分10
5秒前
Hua完成签到,获得积分10
6秒前
uTwTu发布了新的文献求助10
6秒前
6秒前
爱吃秋刀鱼的大脸猫完成签到,获得积分10
6秒前
gaogao完成签到 ,获得积分10
6秒前
蒸点粥七七完成签到,获得积分10
7秒前
曾经友容完成签到 ,获得积分10
9秒前
Molly完成签到 ,获得积分10
9秒前
陨落的繁星完成签到,获得积分10
9秒前
科研dog完成签到,获得积分10
9秒前
CodeCraft的应助被wzz采纳,获得10
10秒前
八笔完成签到 ,获得积分10
10秒前
康家旗完成签到,获得积分10
11秒前
清修发布了新的文献求助10
11秒前
世上千寒完成签到,获得积分10
11秒前
waka完成签到,获得积分10
11秒前
李安全完成签到,获得积分10
12秒前
安然完成签到 ,获得积分10
12秒前
vnewgnl的应助被史萌采纳,获得10
13秒前
闪闪的乐蕊完成签到,获得积分10
13秒前
14秒前
Alice完成签到 ,获得积分10
15秒前
CWH完成签到,获得积分10
15秒前
Zhoup完成签到,获得积分10
16秒前
一蓑烟雨任平生完成签到,获得积分10
16秒前
韩冬完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166570
求助须知:如何正确求助?哪些是违规求助? 9559581
关于积分的说明 21750904
捐赠科研通 7757397
什么是DOI,文献DOI怎么找? 3429170
关于科研通互助平台的介绍 2553530
邀请新用户注册赠送积分活动 2473923